Page last updated: 2024-08-17

levodopa and nad

levodopa has been researched along with nad in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's4 (40.00)18.2507
2000's1 (10.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Lovstad, RA1
Birkmayer, JG; Birkmayer, W; Paletta, B; Vrecko, K1
Birkmayer, GJ; Birkmayer, W1
Debing, I; Ijzerman, AP; Vauquelin, G1
Waring, P1
Lange, KW; Riederer, P; Youdim, MB1
Butler, J; Land, EJ; Prütz, WA1
Danielczik, S; Gerstner, A; Häcker, R; Kuhn, W; Mattern, C; Müller, T; Przuntek, H; Winkel, R1
Abdin, AA; Hamouda, HE1

Reviews

1 review(s) available for levodopa and nad

ArticleYear
Recent advances in pharmacological therapy of Parkinson's disease.
    Advances in neurology, 1993, Volume: 60

    Topics: Antiparkinson Agents; Dopamine Agents; Droxidopa; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Levodopa; NAD; Neurologic Examination; Parkinson Disease; Receptors, Dopamine

1993

Trials

1 trial(s) available for levodopa and nad

ArticleYear
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.
    Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:10

    Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Dihydropteridine Reductase; Enzyme Activation; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; NAD; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Tyrosine 3-Monooxygenase

1996

Other Studies

8 other study(ies) available for levodopa and nad

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effect of penicillamine on the conversion of dopa to dopachrome in the presence of tyrosinase or ceruloplasmin.
    Biochemical pharmacology, 1976, Mar-01, Volume: 25, Issue:5

    Topics: Catechol Oxidase; Ceruloplasmin; Electrons; Free Radicals; In Vitro Techniques; Indolequinones; Indoles; Levodopa; Melanins; NAD; Oxidation-Reduction; Oxygen Consumption; Penicillamine; Quinones

1976
The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients.
    Advances in neurology, 1990, Volume: 53

    Topics: Aged; Disability Evaluation; Humans; Infusions, Intravenous; Levodopa; Middle Aged; NAD; Neurologic Examination; Parkinson Disease

1990
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).
    Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126

    Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Humans; Levodopa; Male; Middle Aged; NAD; NADP; Parkinson Disease

1989
Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
    Molecular pharmacology, 1988, Volume: 33, Issue:4

    Topics: Animals; Cattle; Chloroquine; Chlorpromazine; Electron Transport; Kinetics; Levodopa; Melanins; Melanocytes; NAD; Oxidation-Reduction; Pirenzepine

1988
The time-dependent inactivation of human brain dihydropteridine reductase by the oxidation products of L-dopa.
    European journal of biochemistry, 1986, Mar-03, Volume: 155, Issue:2

    Topics: Adrenochrome; Brain; Dihydropteridine Reductase; Disulfides; Electrophoresis, Polyacrylamide Gel; Humans; Hydrogen Peroxide; Indolequinones; Indoles; Levodopa; NAD; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Peroxidases; Quinones; Time Factors

1986
Photocatalytic and free radical interactions of the heterocyclic N-oxide resazurin with NADH, GSH, and Dopa.
    Archives of biochemistry and biophysics, 1996, Mar-15, Volume: 327, Issue:2

    Topics: Catalysis; Dose-Response Relationship, Radiation; Free Radicals; Gamma Rays; Glutathione; Hydroxyl Radical; Indicators and Reagents; Kinetics; Levodopa; NAD; Oxazines; Oxidation-Reduction; Photochemistry; Spectrophotometry; Time Factors; Xanthenes

1996
Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Neuropharmacology, 2008, Volume: 55, Issue:8

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Levodopa; Mitochondria; NAD; Neurons; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Rotenone; Spectrophotometry; Ubiquinone; Ultrasonography; Vitamins

2008